Giles Coghlan LLB, Lth, MA
Financial Source
The broad conditions for equity buyers remain in place. Easy central bank monetary policy and broad fiscal stimulus mean conditions are suitable for further equity gains. However, investors need to be aware that markets have been trading at elevated levels and are struggling to make new highs despite strong earnings.
Will Illumina move higher in keeping with its very strong seasonal pattern this year? Over the last 15 years, Illumina has gained in value eleven times between June 02 and July 01. The largest gain was in 2019 with a huge 22.04% profit.
Illumina is an American company incorporated in April 1998. Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Summer months can be good months for releasing the latest product developments and proposals. Will Illumina’s strong seasonal pattern lift its share prices again this year?
Major trade risks
-
The main risk to this trade is from any risk-off tones which will weigh on equity prices.
-
A fast rise in US inflation could result in bond tapering which would potentially weaken Illumina's share price if US interest rates are expected to rise.
Our products and commentary provides general advice that do not take into account your personal objectives, financial situation or needs. The content of this website must not be construed as personal advice.
Recommended content
Editors’ Picks
EUR/USD extends gains above 1.0700, focus on key US data
EUR/USD meets fresh demand and rises toward 1.0750 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
GBP/USD extends recovery above 1.2500, awaits US GDP data
GBP/USD is catching a fresh bid wave, rising above 1.2500 in European trading on Thursday. The US Dollar resumes its corrective downside, as traders resort to repositioning ahead of the high-impact US advance GDP data for the first quarter.
Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP
Gold price (XAU/USD) attracts some dip-buying in the vicinity of the $2,300 mark on Thursday and for now, seems to have snapped a three-day losing streak, though the upside potential seems limited.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price.
US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4
The United States Gross Domestic Product (GDP) is seen expanding at an annualized rate of 2.5% in Q1. The current resilience of the US economy bolsters the case for a soft landing.